M.A. Bensmaïne

Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and Fluorouracil Regimen

Thierry André, M.A. Bensmaïne, Christophe Louvet et al. · Journal of Clinical Oncology · 1999 · 280 citations

Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer

P. Chollet, M.A. Bensmaïne, S. Brienza et al. · Annals of Oncology · 1996 · 140 citations

Oncology, Medicine, Pharmacology +6

Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: An investigator-originated compassionate-use experience

Sandrine Faivre, S. Kalla, Esteban Cvitkovic et al. · Annals of Oncology · 1999 · 68 citations

Investigator-originated Compassionate-use Experience, Medicine, Cancer Management +10

Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin ± taxane-pretreated ovarian cancer patients

Véronique Dièras, Philippe Bougnoux, Thierry Petit et al. · Annals of Oncology · 2002 · 67 citations

Oncology, Medicine, Gynecology +5

Oxaliplatin added to 5-fluorouracil-based therapy (5-FU ± FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): Results from the European compassionate-use program

S. Brienza, M.A. Bensmaïne, P Soulié et al. · Annals of Oncology · 1999 · 52 citations · Full text

Gastrointestinal Oncology, Medicine, Cancer Management +10